Related Experiment Video
Updated: Sep 18, 2025
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Exploring the relationship between graft dysfunction with serum metabolites and inflammatory proteins: integrating
Jiyuan Li1, Kankan Shui1, Longkai Peng1
1Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital, Central South University, Changsha, China.
Background:
The exact mechanism of graft dysfunction has not been fully clarified. We aimed to explore the causal effects of serum metabolites on graft dysfunction and the mediating role of inflammatory proteins.
Methods:
We first analyzed the causal association of 1,091 serum metabolites and 91 inflammatory proteins with graft dysfunction by Mendelian randomization (MR) to find the most important indicators and calculated the mediating role of inflammatory proteins. Second, we further intergrated the single-cell analysis, machine learning, and Shapley Additive exPlanations (SHAP) methods to validate the role of the inflammatory protein in rejected transplanted kidneys.
Results:
In MR analysis, the inverse variance weighted (IVW) method showed that N-acetylaspartyl glutamate (NAAG) levels reduced the risk of graft dysfunction (OR 0.648, 95% CI 0.522-0.805). Interleukin-2 receptor subunit beta (IL-2RB) mediated the association between NAAG and graft dysfunction with a mediation ratio of 11.35% (95% CI 1.85%-24.69%). In transplanted kidneys, IL-2RB is predominantly expressed elevated in T cells from rejection samples and is associated with decreased renal function. 10 hub genes were identified based on T cells with high and low expression of IL-2RB, of which NGboost reached AUC 0.77. The SHAP method obtained the gene with the greatest model contribution: the IL-2RB gene.
Conclusion:
NAAG plays a protective role in graft dysfunction, and part of the effect is mediated by inhibition of IL-2RB, which is verified as an important gene that functions in transplant kidney rejection. NAAG and IL-2RB may be novel molecular markers and therapeutic targets for graft dysfunction.
